Tillman Departs: Device Evaluation Director To Leave FDA March 26
This article was originally published in The Gray Sheet
Executive Summary
Office of Device Evaluation Director Donna-Bea Tillman will step down March 26 to join Microsoft's health unit, she said in a March 1 email to her staff